Analyst Consensus ?
ConsensusHold42 ratings
Bullish1740.5%
Neutral2252.4%
Bearish37.1%
FN2 Earnings Intelligence
Zimmer Biomet Holdings, Inc. analyst ratings
Zimmer Biomet Holdings, Inc. (ZBH) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$93.49Previous close
$83Low
$118.98Average
$180High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Sep 14, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Canaccord Genuity | Hold | Hold | Maintain | Aug 10, 2026 |
| Truist Securities | Hold | Hold | Maintain | Aug 7, 2026 |
| Stifel | Buy | Buy | Maintain | Aug 6, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Aug 6, 2026 |
| Bernstein | Market Perform | Market Perform | Maintain | Aug 6, 2026 |
| BMO Capital | Market Perform | Outperform | Downgrade | Jul 9, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 6, 2026 |
| Citigroup | Neutral | Neutral | Maintain | May 28, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Apr 29, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Apr 29, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | Apr 29, 2026 |
| Barclays | Underweight | Underweight | Maintain | Apr 29, 2026 |
| BTIG | Neutral | Buy | Downgrade | Mar 23, 2026 |
| Needham | Hold | Hold | Maintain | Feb 10, 2026 |
| UBS | Sell | Sell | Maintain | Jan 28, 2026 |
| Baird | Neutral | Outperform | Downgrade | Dec 16, 2025 |
| Raymond James | Outperform | Outperform | Maintain | Aug 8, 2025 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | May 7, 2025 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | May 6, 2025 |
| Goldman Sachs | Neutral | Neutral | Maintain | May 6, 2025 |
| Oppenheimer | Outperform | Outperform | Maintain | Oct 15, 2024 |
| TD Cowen | Hold | Hold | Maintain | Sep 6, 2024 |
| Piper Sandler | Neutral | Overweight | Downgrade | Jul 1, 2024 |
| Argus Research | Buy | Hold | Upgrade | May 21, 2024 |
| B of A Securities | Neutral | Underperform | Upgrade | May 3, 2023 |
| Jefferies | Hold | Underperform | Upgrade | Mar 31, 2023 |
| SVB Leerink | Outperform | Outperform | Maintain | May 4, 2022 |
| Loop Capital | Hold | Buy | Downgrade | Mar 2, 2022 |
| Deutsche Bank | Hold | Hold | Maintain | Feb 8, 2022 |
| Northland Capital Markets | Outperform | Market Perform | Upgrade | Apr 9, 2021 |
| Credit Suisse | Underperform | Underperform | Maintain | Nov 9, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | May 12, 2020 |
| Guggenheim | Neutral | Buy | Downgrade | Apr 28, 2020 |
| Argus | Buy | Hold | Upgrade | Aug 12, 2019 |
| Citi | Buy | Buy | Maintain | Aug 2, 2019 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Jul 30, 2018 |
| Stifel Nicolaus | Buy | Hold | Upgrade | Jan 31, 2018 |
| Leerink Swann | Outperform | Outperform | Maintain | Jan 31, 2018 |
| Edward Jones | Buy | Hold | Upgrade | Nov 9, 2017 |
| PiperJaffray | Neutral | Overweight | Downgrade | Nov 2, 2017 |
| Northcoast Research | Neutral | Buy | Downgrade | Nov 8, 2016 |
| Northland Securities | Perform | Outperform | Downgrade | Jan 7, 2016 |
Named analyst price targets
Upside is calculated against the persisted previous close $93.49. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Canaccord Genuity | Caitlin Cronin | $100 | $96.55 | +7.0% | Aug 10, 2026 |
| Truist Financial | Analyst unavailable | $106 | $96.62 | +13.4% | Aug 6, 2026 |
| Robert W. Baird | Analyst unavailable | $104 | $97.32 | +11.2% | Aug 6, 2026 |
| UBS | Patrick Wood | $120 | $97.06 | +28.4% | Aug 6, 2026 |
| Bernstein | Analyst unavailable | $93 | $97.53 | -0.5% | Aug 6, 2026 |
| BMO Capital | Analyst unavailable | $96 | $98.16 | +2.7% | Aug 6, 2026 |
| RBC Capital | Kendall Au | $110 | $98.16 | +17.7% | Aug 6, 2026 |
| UBS | Patrick Wood | $115 | $92.07 | +23.0% | Jul 28, 2026 |
| BMO Capital | Analyst unavailable | $95 | $87.56 | +1.6% | Jul 8, 2026 |
| Truist Financial | Analyst unavailable | $92 | $80.8 | -1.6% | Apr 29, 2026 |
| Canaccord Genuity | Analyst unavailable | $83 | $82.8 | -11.2% | Apr 29, 2026 |
| Stifel Nicolaus | Rick Wise | $105 | $82.8 | +12.3% | Apr 29, 2026 |
| Robert W. Baird | Analyst unavailable | $92 | $82.8 | -1.6% | Apr 29, 2026 |
| Barclays | Matt Miksic | $94 | $82.8 | +0.5% | Apr 29, 2026 |
| Barclays | Matt Miksic | $100 | $96.69 | +7.0% | Feb 12, 2026 |
| UBS | Analyst unavailable | $89 | $93.69 | -4.8% | Feb 11, 2026 |
| UBS | Analyst unavailable | $86 | $85.27 | -8.0% | Jan 28, 2026 |
| Bernstein | Analyst unavailable | $99 | $94.08 | +5.9% | Jan 9, 2026 |
| Goldman Sachs | David Roman | $93 | $94.08 | -0.5% | Jan 9, 2026 |
| Evercore ISI | Analyst unavailable | $120 | $90.02 | +28.4% | Jan 5, 2026 |
| Robert W. Baird | Jeff Johnson | $100 | $92.52 | +7.0% | Dec 16, 2025 |
| Stifel Nicolaus | Rick Wise | $110 | $87.91 | +17.7% | Nov 5, 2025 |
| Johnson Rice | Analyst unavailable | $112 | $88.05 | +19.8% | Nov 5, 2025 |
| Barclays | Analyst unavailable | $105 | $103.18 | +12.3% | Nov 5, 2025 |
| BTIG | Ryan Zimmerman | $122 | $94.71 | +30.5% | Oct 13, 2025 |
| RBC Capital | Analyst unavailable | $111 | $95.52 | +18.7% | Oct 10, 2025 |
| Stifel Nicolaus | Analyst unavailable | $118 | $100.36 | +26.2% | Sep 19, 2025 |
| Redburn Partners | Ed Ridley-Day | $130 | $100.21 | +39.1% | Sep 18, 2025 |
| UBS | Danielle Antalffy | $96 | $97.94 | +2.7% | Aug 8, 2025 |
| Truist Financial | Richard Newitter | $101 | $92.27 | +8.0% | May 6, 2025 |
| RBC Capital | Shagun Singh | $112 | $92.27 | +19.8% | May 6, 2025 |
| Stifel Nicolaus | Rick Wise | $115 | $90.48 | +23.0% | May 6, 2025 |
| Wells Fargo | Larry Biegelsen | $98 | $90.48 | +4.8% | May 5, 2025 |
| Truist Financial | Richard Newitter | $117 | $106.92 | +25.1% | Oct 31, 2024 |
| Oppenheimer | Steven Lichtman | $135 | $104.83 | +44.4% | Oct 15, 2024 |
| BTIG | Ryan Zimmerman | $126 | $105.69 | +34.8% | Oct 3, 2024 |
| Evercore ISI | Vijay Kumar | $110 | $107.95 | +17.7% | Oct 1, 2024 |
| Truist Financial | Richard Newitter | $112 | $105.14 | +19.8% | Sep 13, 2024 |
| Canaccord Genuity | Caitlin Cronin | $115 | $104.83 | +23.0% | Sep 10, 2024 |
| Raymond James | Jayson Bedford | $128 | $107.09 | +36.9% | Aug 8, 2024 |
| Oppenheimer | Steven Lichtman | $145 | $105.81 | +55.1% | Aug 8, 2024 |
| Stifel Nicolaus | Rick Wise | $130 | $107.5 | +39.1% | Aug 7, 2024 |
| Morgan Stanley | Drew Ranieri | $120 | $108.69 | +28.4% | Jul 15, 2024 |
| Piper Sandler | Matt O'Brien | $115 | $108.53 | +23.0% | Jul 1, 2024 |
| Piper Sandler | Matthew O\'Brien | $140 | $114.44 | +49.7% | May 31, 2024 |
| RBC Capital | Shagun Singh | $140 | $115.14 | +49.7% | May 30, 2024 |
| BTIG | Ryan Zimmerman | $139 | $116.41 | +48.7% | May 28, 2024 |
| Argus Research | David Toung | $150 | $119.05 | +60.4% | May 21, 2024 |
| Truist Financial | Analyst unavailable | $137 | $128.46 | +46.5% | Feb 6, 2023 |
| Morgan Stanley | Analyst unavailable | $140 | $128.82 | +49.7% | Feb 6, 2023 |
| RBC Capital | Analyst unavailable | $141 | $125.7 | +50.8% | Jan 9, 2023 |
| Morgan Stanley | Analyst unavailable | $135 | $126.77 | +44.4% | Jan 6, 2023 |
| Truist Financial | Analyst unavailable | $135 | $124.91 | +44.4% | Dec 20, 2022 |
| Citigroup | Analyst unavailable | $130 | $125.36 | +39.1% | Dec 12, 2022 |
| Wells Fargo | Larry Biegelsen | $124 | $115.33 | +32.6% | Nov 23, 2022 |
| Stifel Nicolaus | Analyst unavailable | $120 | $104.62 | +28.4% | Jul 18, 2022 |
| RBC Capital | Analyst unavailable | $128 | $122.2 | +36.9% | May 4, 2022 |
| Piper Sandler | Matt O'Brien | $130 | $121.37 | +39.1% | May 3, 2022 |
| Bank of America Securities | Travis Steed | $120 | $122.13 | +28.4% | Mar 3, 2022 |
| JMP Securities | David Turkaly | $145 | $116.08 | +55.1% | Feb 8, 2022 |
| RBC Capital | Shagun Singh Chadha | $125 | $116.08 | +33.7% | Feb 8, 2022 |
| Truist Financial | Samuel Brodovsky | $128 | $116.08 | +36.9% | Feb 8, 2022 |
| Canaccord Genuity | Kyle Rose | $125 | $108.13 | +33.7% | Feb 7, 2022 |
| Deutsche Bank | Pito Chickering | $121 | $108.13 | +29.4% | Feb 7, 2022 |
| Leerink Partners | Danielle Antalffy | $135 | $108.13 | +44.4% | Feb 7, 2022 |
| Piper Sandler | Matthew O'Brien | $110 | $108.13 | +17.7% | Feb 7, 2022 |
| Robert W. Baird | Jeff Johnson | $138 | $108.13 | +47.6% | Feb 7, 2022 |
| Needham | Michael Matson | $143 | $108.13 | +53.0% | Feb 7, 2022 |
| Cowen & Co. | Josh Jennings | $140 | $119.14 | +49.7% | Jan 20, 2022 |
| Motley Fool | Anders Bylund | $140 | $121.23 | +49.7% | Dec 9, 2021 |
| Jefferies | Anthony Petrone | $175 | $136.9 | +87.2% | Nov 5, 2021 |
| Guggenheim | Christopher Pasquale | $180 | $136.9 | +92.5% | Nov 5, 2021 |
| Evercore ISI | Vijay Kumar | $170 | $133.13 | +81.8% | Nov 4, 2021 |
| Oppenheimer | Steven Lichtman | $190 | $143.03 | +103.2% | Aug 4, 2021 |
Track every rating change on ZBH the moment it posts. Free to start.
Start free